A B S T R A C T A convenient, specific, precise, and reproducible radioimmunoassay system for measurement of triiodothyronine (Ta) in human serum has been developed. The procedure compares the ability of standards and unknowns to compete with radioactive Ta for binding sites on a Ts-binding antiserum produced in rabbits by immunization with human thyroglobulin. The assay is set up in the presence of 250 ng thyroxine (T4) in all tubes, to mobilize T3 from its binding with the thyronine-binding globulin (TBG), and athyreotic sheep serum in standards to correct for the TBG in the unknowns. The method regularly detected 0.4 ng Ts, which would correspond to a Ts concentration of 100 ng/100 ml when 400 ;I of serum is analyzed. The mean recovery of unlabeled Ta added to normal serum pools was 106%. Serial dilution of hyperthyroid sera containing high concentrations of Ta with athyreotic sheep serum yielded expected values.
INTRODUCTION
Triiodothyronine (Ta),' because of its greater potency in comparison with thyroxine (T4) (1, 2) , may be ex- 'Abbreviations used in this paper: HSA, human serum albumin; PBS, phosphate-buffered saline; RIA, radioimmunoassay; Ta, triiodothyronine; T4, thyroxine; TBG, thyronine-binding globulin; TBPA, thyroxine-binding prealbupected to contribute significantly to the over-all metabolic effects of thyroid hormones. In fact, it has been suggested by some that T may exert its effects at the tissue level predominantly via conversion to Ta (3, 4) . A recent report of the occurrence of hyperthyroidism with elevated serum Ta and normal serum T4 (5) further emphasizes the importance of this hormone and the need for accurate methods for its measurement on a large scale.
To date, there is no general agreement regarding serum concentration of this hormone. Thus, the mean values of serum Ts in euthyroid individuals have ranged from 450 ng/100 ml (6) to 330 (7) and 220 (8) to 120 ng/100 ml (9) . Most widely used among the methods available for measurement of Ta in serum are those which involve, sequentially, extraction of thyronines, separation of Ts from T4, and measurement of T3 by a competitive binding method employing thyroxine-binding globulin (TBG). Separation of Ta from T4 involves two possible complications: (a) inadequate separation with contamination of T3 by some T4 (10, 11) , and (b) artifactual deiodination of T4 with resultant formation of T3 (11, 12) ; both of these phenomena would give falsely high estimates of T3.
We have recently reported production of T3 antibodies by immunization of rabbits with human thyroglobulin (Tg) (13) ; these antibodies have led to development of a radioimmunoassay (RIA) method, herein described, for measurement of Ta in whole serum. Several experiments designed to test the validity of the method, and the results obtained by it in human sera are also presented. This method does not require prior extraction or separation of thyronines and involves use of a relatively specific Ta binder, thereby obviating some disadvantages of earlier methods. The method has the additional advantage of allowing a large number of samples to be tested per week by a single technician, which might make wide clinical application feasible. min; TETRAC, tetraiodothyroacetic acid; Tg, thyroglobulin; TRIAC, triiodothyroacetic acid.
METHODS
Introductory comment. The basic approach to measurement of T3 by RIA was similar to that described earlier (13) . The following modifications in the method were made for adapting it to measurement of the hormone in serum. (a) Addition of an equal excess of cold T4 to all standards and unknown sera for three purposes: (i) to displace T3 bound to TBG and to make it available for reaction with Ts antibody and thus measurable by RIA; (ii) to minimize binding of radioactive and nonradioactive T3 to TBG; (iii) to equalize the amount of a cross-reacting ligand, i.e., T4.
The concentration of T4 was adjusted to 250 ng/400 Al of test serum after taking into consideration the amount already present in serum as measured by the method of Murphy (14) . This amount of T4 corresponded to a T4 concentration of 25 ,ug/100 ml in 1 ml of the reaction mixture containing 400 Al serum or to 62.5 ,ug/100 ml if the concentration of T4 was referred to whole serum.
(b) Addition of a source of TBG to the standards in order to make them comparable with the unknown serum specimens. This is essential since TBG binds T3 and, therefore, competes with T3-binding antibody. Any labeled T3 bound to TBG would not be precipitated by antiserum against rabbit gamma globulin ("second antibody") and thus would imitate the effect of additional unlabeled T,. This modification was made by adding to the standards serum of a hypothyroid sheep obtained 21 days after total surgical thyroidectomy. Sheep serum was chosen as a source of TBG because it is most comparable with human serum among commonly available laboratory animal species (15) .
Reagents. T3-binding antiserum. The serum used was obtained from a rabbit (No. 15) immunized for 12 wk with normal human Tg, as previously described (13) . 100 A.l of a 1: 40 dilution was added in a total reaction mixture of 1.0 ml, yielding a final dilution of 1: 400. In this dilution it bound 75-80% of a tracer amount of radioactive T3, when T4 or TBG was not present. However, the binding of the tracer ranged between 25 and 34% when 400 Al of sheep serum and 250 ng of T4 were present in 1 ml of reaction mixture.
Hypothyroid sheep serum. Total T4 in the sheep serum was 4.7 ,ug/100 ml before surgical total thyroidectomy, and it had dropped to < 1.0 Ag/100 ml at the time of bleeding 3 wk postoperatively. Serum Ta at this time, tested on four different occasions by chemical method (16) , was less than 25 ng/100 ml.a T4-binding capacity of the TBG of the hypothyroid sheep serum was 32 ,ug/100 ml, measured by the method of Inada and Sterling (17) . Radioiodinated ('I or 'I) T3 and T4 (SA 50-70 Aci/ pAg) in 50%o propylene glycol were obtained from Abbott Laboratories, North Chicago, Ill.
Reagent grade Na-L-T4 and Na-L-T3 were obtained from Mann Research Labs., New York. The thyronines were weighed, dissolved in 0.1 M NaOH, and diluted to the desired concentration in a solution made up of 100 parts 0.01 M NaOH, 50 parts propylene glycol, and 3 parts normal rabbit serum. The contribution of sodium and/or water in salts of T3 or T4 was considered in making dilutions. The same solutions were used up to 10 days without evident deterioration during storage in the dark at 40C. The Na-L-T4 was tested for contamination with T3 using a T3-binding antiserum, prepared by immunization of rabbits with a conjugate of T3 with human serum albumin (HSA) by of a previously titered goat anti-rabbit -y-globulin was added, and the tubes were reincubated for 20-24 hr. They were then centrifuged at 2000 rpm for 30 min, the supernatant was aspirated, and radioactivity in the precipitates was determined by 10-min counts in a Nuclear-Chicago Autogamma counter. Each assay additionally included two tubes without Ts-binding rabbit antiserum; the counts precipitated in these tubes, which ranged from 2 to 3%o of total counts added, were taken to be nonspecifically bound or trapped in the final precipitate and were subtracted from the counts in all tubes. In each assay run there were also at least two tubes which contained all reagents outlined above except nonradioactive Ta. The counts precipitated in these tubes were arbitrarily assigned a value of 100l%, and the counts in the other standards and unknowns were expressed as a per cent of the counts in the zero-T3 tubes. A standard curve was plotted as shown in Fig. 1 Sources of sera. 31 euthyroid sera were tested. 20 were from normal, healthy laboratory workers, and 11 were from patients with nonthyroid diseases.
Sera were obtained from 24 untreated hyperthyroid patients with Graves' disease and 4 patients with idiopathic hypothyroidism. The diagnosis was verified by clinical examination, serum total T4, and thyroid uptake of radioiodine. In addition, sera were obtained from sequential blood samples from a patient who had ingested 90 tablets of thyroid USP (3 grains each) in a suicidal attempt.
Sources of serum with elevated serum TBG concentration were three patients with carcinoma of the prostate receiving stilbesterol, 10-15 mg/day, one postpartum woman receiving stilbesterol, 5 mg/day, and three normal women receiving contraceptive pills.
Assessment of validity of method. The validity of the entire method and particularly the suitability of sheep serum as a source of TBG in the standard tubes to match the human TBG in unknown sera was assessed by testing (a) the recovery of varying amounts of nonradioactive Ts added to 400 1el of various pools of human serum, and (b) the T3 concentration in several dilutions of Ts-rich sera-from hyperthyroid patients using sheep serum as the diluent. Other attempts to validate the results of T3 concentration in human sera as measured by the proposed RIA included the following: (a) Measurement of T3 in thyronine concentrates of sera. Thyronines were extracted from 8 to 10 ml sera by passing through a column of anion exchange resin (Bio-Rad AG X2) chloride form, 200-400 mesh as described by Dussault, Lam, and Fisher (16) . Approximately 25,000 cpm of T3-'I was added for later recovery calculations. All of the eluate with 50%' acetic acid was collected rather than discarding the first 4 ml (which contains predominantly T4) as described by Dussault et al. (16) . The eluates were dried in a water bath at 40°C under a stream of nitrogen. At this point the recovery of Ts-'I averaged 69% (range, 61.5-78%). The dried extract was reconstituted in 0.9 ml of methanol-2 N NH40H (99:1). 400 ,l of the extract was transferred in duplicate to 10 X 75 mm assay tubes, and counted with a gamma counter to determine the proportion of starting sample represented by this extract and the amount of Ts represented by radioactive T3. Assuming T4 was extracted with the same efficiency as T3 and measuring the T4 concentration in the starting serum Murphy (14) , the amount of T4 in this extract was also estimated. Cold T4 in 70% alcohol was then added to the extract to adjust the total T4 in the tube to 500 ng. For the standard curve, tubes containing 500 ng T4 and varying amounts of T3 were prepared. All tubes were dried at 40°C under a stream of nitrogen. To all tubes 100 ,.d EDTA, 200 ,ul PBS, 500 I-l 5% HSA, 100 ,ul 1:20 dilution of T3-binding antiserum, and 100 Al Tv-!I were then added and incubated as described. The radioactivity bound to rabbit T3-binding antibody was separated by precipitation with a goat antiserum against rabbit yglobulin. The standard curve was plotted as described above. (b) Measurement of T3 in human sera by using anti-T3-HSA (vide supra) in the RIA procedure described above.
Assessment of sensitivity. The threshold was defined as the smallest amount of nonradioactive T3 in the presence of which the radioactivity bound to antibody was significantly lower (P <0.05) than in the tubes with no nonradioactive T3. It was determined in standard curves run in triplicate or quadruplicate.
RESULTS
Standard curve. Fig. 1 shows a typical standard curve obtained in the presence of 400 1 sheep serum and 250 ng T4.3 The index of precision (X) was 0.07.
'With T4 addition of 500 and 1000 ng per 400 ,u sheep serum, the standard curves were shifted progressively to the right thereby resulting in fall in sensitivity. The detection threshold for T3 was approximately 0.75 ng for 500 and approximately 1.0 ng for 1000 ng T4. The threshold was 0.4 ng in this assay and varied between 0.3 and 0.4 ng in other runs, corresponding to a T3 concentration of 75 and 100 ng/100 ml, respectively.
Specificity. The relative avidity of various thyroid analogues for the T3-binding sites in the rabbit antiserum is presented in Table I . The dose-response curve with D-T3 was almost superimposible on that of L-Ts, whereas that of TRIAC and triiodothyropropionic acid was to the right of and essentially parallel to the dose-response curve obtained with L-T3 (Fig. 2) . Other thyroid analogues reacted minimally in the system. Some other compounds which might be of interest in connection with the assay of T3 were also studied. Dilantin, mercury, and iodide had no discernible effect in concentrations up to 10 mg, 2 mg, and 4 g per 100 ml, respectively. Human Tg had no effect with additions of up to 1000 ng/assay tube. An addition of 10,000 ng of Tg caused displacement of Ta-'I from antibody equivalent to that by 1.4 ng T3.
Serum Ts concentration in health and disease. The range of serum Ts concentration in various sera is presented in Fig. 3 . The majority of the normal sera, 25 of 31, contained T3 in a concentration less than the detection threshold of the method, i.e., 100 ng/100 ml; among the six sera in which Ta was detectable, the values were 100 in two, 110 in another two, and 150 and 170 ng/100 ml in the remaining two individuals. Among the 27 sera from hyperthyroid patients, Ta was detected in 25, with a range from 160 to 1300 ng/100 ml (mean, 519).
T4 and T3 concentrations in serial bleedings of 10 Graves' disease patients during treatment with antithyroid drugs are presented in Table II . In all patients serum T3 decreased toward or to normal levels during therapy. In some, the fall of T4 to normal levels was more rapid, whereas in others T3 fell more rapidly. T4 and T3 concentrations during relapse of hyperthyroidism in three patients are also presented in this Table. Hyperthyroidism had recurred within 4 wk of the termination of a 1 yr course of antithyroid drug therapy in all three of these patients. In two of these patients in whom serum Ts concentration before treatment was measured, it was much higher at the time of relapse than before treatment, whereas the converse was true with regard to serum T4 concentrations. Fig. 4 t Micrograms/100 milliliters. § Nanograms/100 milliliters.
i.e., T3. The mean (+SEM) value for per cent departure of duplicates from their mean in the same assay was 4.84 ±0.78. To examine reproducibility, a comparison was made of the mean Ts concentrations of 9 sera run in duplicate in different assays. The coefficient of correlation was 0.9572, indicating that 9% of the total variance was due to methodologic variation of which approximately two-thirds is attributable to day-to-day factors and onethird to within assay factors (see above). The mean (+SEM) value for per cent departure of duplicates from their mean in different assays was 6.67 +1.30.
Validation of the method. To examine the applicability of sheep serum in standards, the recovery of cold Ta from five different pools of normal sera was examined. In 15 experiments where 0.5-10 ng of Ts was added to 400 Al normal human serum the mean (+SEM) recovery of Ts was 106.5 (±+4.4) %.
When serial dilutions were made by adding sheep serum to serum of hyperthyroid patients, the results varied randomly around expected values (Table IV) .
To check by chemical means the results obtained in normal subjects, sera of four normal laboratory workers, which appeared to contain less than 100 ng/100 ml of Ts as measured by RIA, were extracted to concentrate Ts. Accounting for recovery, an extract representing about 3 ml of serum was analyzed for Ts concentration using the Ta-binding antiserum. Ta content in these extracts could now be read in the midportion of the standard curve. The Ts concentration in these sera was 97, tained with varying amounts of nonradioactive Ts. The same was true with anti-T3-HSA. With this antiserum, 100 Al of sheep serum caused displacement of radioactive T3 from antibody equivalent to that with 0.90 ng of nonradioactive Ta. As the sheep serum actually contained minimal Ta (less than 25 ng/100 ml), this pronounced displacement must be predominantly due to its TBG content. Similarly, 100 Al of the sera from five normal subjects seemed to be equivalent to 0.68-1.2 ng of unlabeled Ta (mean 0.96) which would be equivalent, it should be noted, to from 680 to 1200 ng/100 ml. 100 Al of five hyperthyroid sera appeared to behave like 0.95-1.35 ng of Ta (mean 1.12 ng). As some of the displacement of radioactive Ta from antibody observed in the case of human sera may be expected to be due to their Ts content, it became pertinent to know the Ts concentration which would be measured if no T4 were added in the regular RIA system. When this was done, a fairly satisfactory standard curve was obtained, adding Ts freshly to sheep serum as in the usual RIA. However, in human serum, where the Ta was already firmly bound to TBG, it apparently was not free to It was thus evident that the addition of excess To is necessary in order to be able to measure Ts in human serum and that the displacement of Ta-l'I from antibody by human sera in the absence of added T4 could be, if anything, only minimally due to their Ts content and was essentially due to TBG (not thyroxine-binding prealbumin [TBPA] as this does not bind Ta to any significant extent [19] ). Effect of varying amounts of TBG in the presence of excess unlabeled T4. The marked displacement effect of sheep serum on the binding of radioactive Ta to antibody described above became much less pronounced when the same experiment was conducted in the presence of excess T4 (250 ng). If one expressed the per cent Ts-lI bound to antibody in the presence of 400 Al sheep serum and 250 ng T4 as 100% (as has been done regularly in the RIA described), a reduction of the volume of sheep serum to 300 Al increased the binding to antibody by only 2% and a reduction to 200 Al increased it by another 4%. Conversely, an increase of sheep serum to 600 Al decreased the binding of Ts-'I to antiserum by only 10%. Presumably, then, in this system at least, a variation of ±25% in TBG concentration in the human sera as compared with the sheep Although 250 ng of T4 may not be enough to saturate completely the binding sites on the amount of TBG in 400 Al of serum, the results indicate that it is adequate to mobilize at least 5 ng of Ts (5.2 ng T3/400 Al sample = 1300 ng/100 ml, the highest value obtained in our studies). At equilibrium, it is possible that a proportion of Ta may be actually bound to TBG, but the same would apply to the radioactive Ta added, both to the samples and the standards. The method reported here, like any RIA, must be viewed as depending entirely on a comparison between the standards and unknowns. It appears that essential identity was achieved by the methodologic modifications used in our method.
The sensitivity of the method was such that it should have readily detected Ta in all normal sera if the serum Ta concentration in such sera were above 170 ng/100 ml, as reported by other methods (6) (7) (8) . However, with the values obtained being less than 100 ng/100 ml (i.e. <0.4 ng/400 Al) in most normal subjects, sensitivity remains a major problem. It may be noted that the same Ts-binding antiserum, when used without excess T4 and sheep serum, can easily detect 0.1 ng Ts/assay tube (13) . Reduction in sensitivity due to the additions was not unique to this antibody but was also noted with anti-T3-HSA. With this antiserum, sensitivity has been reported to be 0.05 ng/assay tube (18) , but it dropped to 0.4 ng when excess To and hypothyroid sheep serum were added as described above.
The Ta concentration in euthyroid individuals reported here is lower than that found by previous methods (6) (7) (8) . The mean normal value by the most commonly used method is 220 ng/100 ml (8 (10) (11) (12) . When Benotti, Grimaldi, Pino, and Maloof (10) analyzed the Ts isolated from paper chromatography by gas chromatography, significant contamination by T4 (a 0.5%) was observed. Considering the mean serum T4 concentration in euthyroid individuals to be 6.48 Ag/100 ml (20) , 0.5% of T4 could raise the estimates of Ta concentration by about 80 ng/100 ml, since T4 causes 2.5 times greater displacement of radioactive Ts from TBG than an equal weight of Ta (12) . In fact, this does seem to be the case. Recently, using a binding protein 30 times more specific for Ta than T4, Ekins, Brown, Ellis, and Reith have reported Ts concentrations in normal sera ranging between 70 and 160 ng/100 ml (mean 120 ng) (9). Hollander, using a gas chromatographic method, has reported earlier a mean serum Ts concentration even higher than that obtained by other methods (6) . However, later investigations from his laboratory have indicated that those values may have been spuriously elevated. Changes in the method have lowered his estimate of mean normal Ta concentration to approximately 138 ng/100 ml, which would be more comparable with the results reported in the present study. ' Dussault et al. (16) , using a chemical method, have carefully investigated the inadequacies of separation of thyronines as well as the contribution of Ts derived from in vitro deiodination of T4 to the final estimate of Ta concentration. When they correct the Ts concentration for methodological artifacts, the values obtained in normal subjects range from less than 25-203 ng/100 ml (mean 98+±48). 61% of 31 normal subjects tested had a serum Ta concentration less than 100 ng/100 ml, in close agreement with the results reported in this paper.
The RIA method affords an adequate, but by no means perfect, separation of hyperthyroid patients from normal subjects and hypothyroid patients. 89% of hyperthyroid patients had a serum Ta concentration above upper limit of normals (170 ng/100 ml). Similarly, diminution in serum Ts concentrations in hyperthyroid patients during treatment indicated the usefulness of the 4 Hollander, C. S. Personal communication.
method in following the response to therapy. However, the method does not distinguish hypothyroid patients from most euthyroid subjects.
Turnover of T3 has been calculated to approximate 60 pg/day (21) in comparison with about 90 Ag/day of T4 (22) . This estimate of T3 turnover is based on a turnover rate of 52% per day, a volume of distribution of 43 liters and a mean serum Ts concentration of 273 ng/100 ml (21) . However, more recent work has described T3 degradation rate as approximately 70% per day, corrected for newly formed iodoprotein, and the volume of distribution has been in the range of 26-35 liters (23).5 Using these figures and a median normal serum Ts concentration of less than 100 ng/100 ml, as reported here, it would seem that the normal Ts utilization rate should be less than 25 tg a day. As Ts is about 3-4 times as potent in its metabolic effect as T4, even this lower estimate does not minimize the possible significance of the contribution of Ts to total thyroid hormone economy.
